Shire Human Genetic Therapies Expands Footprint In Cambridge, Massachusetts’ Kendall Square
11/23/2016
According to BioMed, the 12-year lease for 343,000 square feet of office space in the global life science center of Cambridge is an expansion of the existing presence of the biotechnology company, which is focused on serving people with rare diseases and other highly specialized conditions. Shire is expected to move into the building by early 2019, shortly after the scheduled lease expiration with the current tenant.
"We're extremely pleased that Shire is expanding its Cambridge presence with us as a continued real estate partner," said Tim Schoen, CEO & President of BioMed Realty. "500 Kendall Street is one of our most well-known buildings, with its unmatched location in the heart of Kendall Square, providing the ideal space and location for a leading global company like Shire to continue its growth."
Shire also occupies approximately 206,000 square feet at BioMed Realty's 650 East Kendall Street building. Extending into the new space at 500 Kendall Street is the next step for Shire's expansion of its Rare Disease Innovation Hub within Kendall Square, as the global company increases its Cambridge footprint immediately adjacent to 650 Kendall Street. Expanding into 500 Kendall Street will support the company's longer-term growth plans in Cambridge's thriving life science community.
"500 Kendall has been an important part of the biotech landscape since it opened in 2002. It is an architecturally and environmentally significant building, and we are thrilled to establish a home there," said Mike Shires, Head of Global Business Services for Shire. "The proximity to our existing building at 650 Kendall provides us with a unique opportunity to create a campus setting in the heart of the Cambridge life sciences cluster."
"Shire's plans to continue its growth in Cambridge with our expanded partnership is another testament to the vitality of this life science real estate market," said Bill Kane, Senior Vice President of East Coast Leasing at BioMed Realty. "We're seeing continued robust demand for space in and around Kendall Square, Rogers Street and across Cambridge, with companies like Shire recognizing this high demand and securing space in an unmatched location with exceptional amenities where they can grow for many years to come."
BioMed Realty currently owns and operates approximately 2.6 million of rentable square feet of office and lab space in Cambridge.
Project Announcements
PEAK Precision Manufacturing Plans Bowling Green, Kentucky, Operations
07/26/2024
Italy-Based Sipcam Agro USA Upgrades Wayne County, Mississippi, Operations
07/26/2024
Cleveland-Cliffs Plans Weirton, West Virginia, Operations
07/26/2024
IDEXX Laboratories Plans Wilson, North Carolina, Production Operations
07/26/2024
Germany-Based Ritz Instrument Transformers Plans Waynesboro, Georgia, Operations
07/26/2024
AirJoule Plans Newark-Wilmington, Delaware, Operations
07/26/2024
Most Read
-
19th Annual Area Development Gold and Silver Shovel Awards
Q2 2024
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
The CHIPS and Science Act will bring jobs back to the United States
Q2 2024
-
2023 Top States Commentary: Top-Ranked States Have What It Takes to Win Mega Projects
Q3 2023
-
The Bring Your Own Energy (BYOE) Party Is Starting
Q2 2024
-
Midwest becomes hotspot for semiconductor manufacturing and supply industries
Q2 2024